Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M607964200 on September 27, 2006

J. Biol. Chem., Vol. 281, Issue 47, 36236-36240, November 24, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/47/36236    most recent
M607964200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H. R.
Right arrow Articles by Johnson, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H. R.
Right arrow Articles by Johnson, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Fidelity of the Human Mitochondrial DNA Polymerase*

Harold R. Lee and Kenneth A. Johnson1

From the Department of Chemistry and Biochemistry, Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas 78712

Received for publication, August 21, 2006 , and in revised form, September 27, 2006.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
We have quantified the fidelity of polymerization of DNA by human mitochondrial DNA polymerase using synthetic DNA oligonucleotides and recombinant holoenzyme and examining each of the possible 16-base pair combinations. Although the kinetics of incorporation for all correct nucleotides are similar, with an average Kd of 0.8 µM and an average kpol of 37 s-1, the kinetics of misincorporation vary widely. The ground state binding Kd of incorrect bases ranges from a low of 25 µM for a dATP:A mispair to a high of 360 µM for a dCTP:T mispair. Similarly, the rates of incorporation of incorrect bases vary from 0.0031 s-1 for a dCTP:C mispair to 1.16 s-1 for a dGTP:T mispair. Due to the variability in the kinetic parameters for misincorporation, the estimates of fidelity range from 1 error in 3563 nucleotides for dGTP:T to 1 error in 2.3 x 106 nucleotides for dCTP:C. Interestingly, the discrimination against a dGTP:T mismatch is 16.5 times lower than that of a dTTP:G mismatch due to a tighter Kd for ground state binding and a faster rate of incorporation of the dGTP:T mismatch relative to the dTTP:G mismatch. We calculate an average fidelity of 1 error in 440,000 nucleotides.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
The mitochondrial genome encodes 13 proteins involved in oxidative phosphorylation, 2 rRNAs, and 22 tRNAs. The observed mutation rates in human mitochondrial DNA are 20-100-fold higher than that of nuclear DNA (1), and mutations within, and depletion of the mitochondrial genome are known to cause several chronic degenerative diseases affecting all systems of the body. Point mutations within the mitochondrial DNA (mtDNA) are associated with diseases including but not limited to autism, hearing loss, cardiomyopathy, and adult onset leukemia (2-7). Large scale depletions are known to be associated with diseases including Kearns-Sayre syndrome and Leber hereditary optic neuropathy (8, 9).

Administration of nucleoside analogs as part of the highly active antiretroviral therapy to combat human immunodeficiency virus infections (10) causes duration-dependent mitochondrial dysfunction. Inhibition of mtDNA replication and the resulting mitochondrial DNA depletion leads to oxidative stress, increased mtDNA mutation, and decreased mitochondrial function (11). It has been proposed that energy decline resulting from mtDNA depletion increases oxidative stress, which can ultimately lead to mutations in the mitochondrial genome (12). Side effects experienced by patients treated with nucleoside analogs include peripheral neuropathy, cardiac and skeletal muscle myopathy, pancreatitis, and bone marrow suppression (12, 13), attributable to decreased mtDNA content.

Previous analysis of the discrimination against nucleoside analog reverse transcriptase inhibitors (NRTIs) by human mitochondrial DNA polymerase (Pol {gamma})2 has defined a toxicity index based upon the increased time required to replicate the mitochondrial genome when NRTIs are present (14, 15). The toxicity index reflects the toxicity observed when these nucleoside analog reverse transcriptase inhibitors are assayed in vivo and used clinically. Future drug design efforts, with the aim of decreasing toxicity, should be facilitated by a detailed understanding of the function and fidelity of the human mitochondrial DNA polymerase.

Pol {gamma} is a nucleus-encoded enzyme responsible for the replication of the 16.5-kil-base mitochondrial genome. Mutation rates have been estimated using gain or loss of gene function assays or nucleotide reversion frequency assays to be ~1in 500,000 (16-19). Recently, a link between mitochondrial DNA mutation and aging has been established using homozygous knock-in mice (20). Mice expressing an exonuclease deficient form of Pol {gamma} exhibit a 3-5-fold increase in the level of point mutations. This increase in mitochondrial DNA mutation is associated with the onset of age-related phenotypes including hair loss, subcutaneous fat loss, weight loss, curvature of the spine, reduced fertility, enlargement of the heart, osteoporosis, and anemia (20).

To date there has been no exhaustive study of the fidelity of Pol {gamma}, examining the incorporation kinetics of all 16 possible base pairs. Steady-state experiments have suggested that the majority of errors made by Pol {gamma} are substitution errors and those caused by the incorporation of dNTPs opposite bases that are not their Watson-Crick base pairing partners (21). A study using another Pol A family enzyme, the Klenow fragment of DNA Pol I, showed that of all of the 12 possible incorrect pairings, a dGTP incorporated onto a template dTMP was the most common mutation (22). Additionally, single nucleotide incorporation assays showed that the fidelity of Klenow fragment manifests from a ~25-fold increase in the Kd for ground state binding and an ~3000-fold decrease in the rate of incorporation on the average. For dGTP onto a dTMP, the Kd increase is ~5-fold, and the rate decrease is but ~900-fold. The authors suggest that the differences in kinetic data between dGTP: dTMP and dTTP:dGMP misincorporations may be due to the geometric asymmetry of the purine-pyrimidine mispairs relative to normal Watson-Crick base pairs.

This report expands upon previous work from this laboratory (23) detailing the kinetic parameters governing the fidelity of human Pol {gamma} polymerization under single turnover conditions utilizing a defined primer-template system. Pol {gamma} is thought to be a heterotrimer (24) consisting of a single catalytic subunit (140 kDa) and two accessory subunits (54 kDa) with no known catalytic activity. Because both subunits are nucleus-encoded and transported to the mitochondria, the genes of the recombinant proteins were truncated to mimic the removal of the mitochondrial import leader sequences (25, 26). The catalytic and accessory subunits were combined in a 1:5 molar ratio needed to saturate the binding to reconstitute the holoenzyme. To probe the fidelity of human Pol {gamma}, we challenged an exonuclease deficient mutant (E200A) with incorrect dNTPs and measured the kinetic parameters of mismatch polymerization. In the accompanying paper we examine the kinetics of incorporation of 8-oxo-7,8-dihydroguanosine triphosphate, a common oxidative metabolite of dGTP (27).


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Enzyme Subunits—Expression and purification of Pol {gamma}A and Pol {gamma}B were accomplished as previously described (25, 26). The expression, purification, and characterization of an exonuclease-deficient mutant of Pol {gamma}A has been previously reported (23) and has been shown to be identical to the wild type enzyme. Experiments to assess the polymerization fidelity were performed as described previously (23) using the reconstituted holoenzyme, consisting of a catalytic subunit containing a 29-amino acid truncation and an accessory subunit containing a His6 tag and a 56-amino acid terminal truncation. Protein concentrations were determined by active site titration against a known concentration of duplex DNA (25). A 1:5 ratio of catalytic subunit to accessory subunit was used for holoenzyme reconstitution based upon a measured Kd of 35 nM and a typical enzyme concentration of 50-100 nM.

Preparation of DNA-DNA Substrate—Primer strands were 5'-32P-labeled with T4 polynucleotide kinase as per manufacturer's instructions (Invitrogen). Termination of the reaction was accomplished by heating the reaction to 95 °C for 5 min. Excess 32P-labeled nucleotide was removed using a Biospin 6 column (Bio-Rad). Primer-template annealing was accomplished by mixing equimolar ratios of 25-mer primer and 45-mer template, heating the mixture to 95 °C, and allowing it to cool slowly to room temperature. The sequences of primer-template substrates used are listed in Table 1.


View this table:
[in this window]
[in a new window]

 
TABLE 1
DNA primer/template sequences used to examine incorporation

 
Assay Conditions—Assays were performed at 37 °C in a buffer containing 50 mM Tris-Cl, pH 7.5, 100 mM NaCl, and 2.5 mM MgCl2. The catalytic holoenzyme-DNA complex was assembled in a MgCl2-free buffer, then mixed with the appropriate nucleotide, previously diluted into a MgCl2 containing buffer, at a 1:1 ratio to initiate the reaction. Because mixing of the enzyme-DNA with the nucleotide is at a 1:1 ratio, each solution is assembled at twice the reported final concentration.

Product Analysis—Products were separated on 15% denaturing polyacrylamide sequencing gels, imaged on a storm 860, and quantified using ImageQuant software (GE Healthcare).

Kd and Maximum Rate of Polymerization for Incorrect Nucleotide Incorporation—To examine the effects of nucleotide concentration upon the rate of polymerization, single nucleotide incorporation experiments were performed. Because it was expected that the rates of incorporation of incorrect nucleotides would be slower than the rate of dissociation of the enzyme from the DNA substrate and to eliminate the complications associated with multiple turnovers of the enzyme, these assays were carried out under single turnover conditions, with enzyme in slight excess over DNA. Reactions were generally carried out from 0 to 30 min, and the time course of product formation was fit to a single exponential ([product] = A x e-kt + C). Rates of polymerization determined from the single exponential were plotted against nucleotide concentration and fit to a hyperbola (observed rate = kpol x [dNTP]/(Kd + [dNTP])) to determine the dissociation constant, Kd, and the maximum rate of polymerization, kpol, for each incorrect nucleotide.

A Note on Terminology—Throughout the paper we will use the shorthand notation for a base pair as dGTP:dC, for example, where dGTP is the incoming nucleoside triphosphate, and dC is the template base.


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Exonuclease-deficient Pol {gamma} was used for these misincorporation experiments because neither creation of a mismatch nor extension beyond a mismatch have been observed in the presence of exonuclease function (23, 28, 29). Moreover, because the rate of polymerization is as slow or slower than the rate of dissociation of the holoenzyme from the DNA substrate and to minimize the complication due to multiple enzyme turnovers, experiments were conducted with enzyme in excess over DNA. Under these conditions we examine the kinetics of a single turnover. We investigated the incorrect incorporation of nucleotides onto templates containing a dCMP, dGMP, or dAMP at the position of incorporation. Previous studies have reported the correct incorporation kinetic parameters of all four nucleotides and for incorrect incorporation opposite a template dTMP (23). Additionally, this same work showed that single nucleotide incorporation assays accurately reflect the kinetics of polymerization under conditions of multiple incorporations.

Fig. 1 illustrates representative data defining the kinetics of formation of an A:A mismatch. The rates were determined by fitting to a single exponential function defining the formation of product versus time. The rates were then plotted against the nucleotide concentration and fit to a hyperbola to yield a Kd of 25 ± 7 and a kpol of 0.0036 ± 0.0003. Kinetic parameters for the incorporation of all 16 correct and incorrect nucleotide base pairs are summarized in Table 2. In Fig. 2 comparisons between various kinetic parameters are illustrated bar graphs.


View this table:
[in this window]
[in a new window]

 
TABLE 2
Kinetic parameters of nucleotide incorporation

 


Figure 1
View larger version (26K):
[in this window]
[in a new window]

 
FIGURE 1.
Misincorporation of dATP onto a template dAMP. A, the upper graph shows the time-course of dATP misincorporation at several dATP concentrations ranging from 1 to 500 µM. The time-courses were fit to the single exponential equation (A x e-kt + C)) to determine the kapp for each reaction. B, the lower graph shows the plot of the rates versus the dATP concentration, fitted to a hyperbolic function. From the fit, we have determined that the Kd for dATP binding is 25 ± 7 µM, and the kpol for the reaction is 0.0036 ± 0.0002s-1.

 
The studies presented here expand upon previous work examining the fidelity of Pol {gamma}. These data provide estimates of the specificity constant for each base pair combination as the ratio kpol/Kd. Nucleotide discrimination is then defined by the ratio D = (kpol/Kd)correct/(kpol/Kd)incorrect. The probability of a misincorporation can then be computed by 1/(D + 1) when competing nucleotides are at the same concentration.

Based upon evidence favoring a rapid equilibrium of nucleotide binding, Kd and kpol measured in single turnover experiments define Km and kcat, respectively, and thus, define the specificity constant, kcat/Km. In this context we consider the theoretical values for kcat and Km assuming these parameters could be measured accurately during steady-state processive synthesis and ignoring practical problems precluding accurate measurements in the steady state as discussed below. The equality Kd = Km has been shown to be approximately correct because nucleotide ground state binding appears to be in rapid equilibrium (30, 31). Evidence supporting rapid equilibrium of the ground state for human Pol {gamma} has been reported previously based largely upon lack of evidence to the contrary (23).

The maximum rate of polymerization at saturating nucleotide, kpol, defines a parameter equating to kcat for processive synthesis. For the past decade it has been debated whether the chemistry step or a conformational change limits kpol, and further studies on Pol {gamma} will be required to establish whether a nucleotide-induced conformational change limits the rate of nucleotide incorporation. However, recent evidence on T7 DNA polymerase has indicated that it does not matter which step is rate-limiting. Rather, the reverse of the conformational change step determines specificity in that a good substrate is committed to continued forward reaction by the slow release of tightly bound nucleotide (31). In contrast, a bad substrate dissociates from the enzyme faster than it is incorporated. Although we do not yet know whether a conformational change step contributes to selectivity by Pol {gamma}, the more detailed analysis afforded in studies using T7 DNA polymerase justify the use of kpol/Kd to measure kcat/Km most accurately. Pol {gamma} and T7 DNA polymerase are both Pol A family enzymes and share significant sequence conservation near the active sites.

The specificity constant (kcat/Km) represents the limiting slope of the concentration dependence of the rate of incorporation at low substrate concentration. As such, it has been argued that one could measure kcat/Km under steady-state conditions even though the rate of polymerization is limited by DNA release (32). That is, the concentration dependence of the rate of steady-state single nucleotide incorporation should, theoretically, give a measure of specificity even though this rate is limited by the rate of DNA dissociation (21). However, given that the average kcat/Km for correct incorporation by Pol {gamma} is 46 s-1 µM-1 and the rate of DNA dissociation is 0.02 s-1, then the expected apparent Km is 0.4 nM for steady-state single nucleotide incorporation. Concentrations of nucleotides required to accurately measure kcat/Km using steady-state methods are too low to generate a signal in the assay, and this could explain the aberrant results reported using steady-state methods (33).

Inspection of Fig. 2 reveals several observations. Although the results may reflect sequence context effects for the particular oligonucleotides chosen for this study, some of the trends appear to be more generally applicable. As a general rule, purine-pyrimidine base pairs are favored over purine-purine and pyrimidine-pyrimidine base pairs. This observation supports the notion that the overall size of the base pair is an important determinant (34). With the possible exception of dGTP:dA, incorporations onto dT and dG appear to be favored over dC and dA, within a base pair subgroup (Pur-Pyr, Pur-Pur, etc). Rates of incorporation disfavor identical base pairings over all others, whereas ground state binding disfavors nonidentical purine-purine/pyrimidine-pyrimidine base pairs. However, the differences in specificity constants and discrimination observed when comparing mismatches to each other are small compared with the much greater differences observed comparing correct incorporations and mismatches to each other as groups. The largest difference in specificities observed is 800-fold when comparing mismatch to mismatch (dGTP:dT compared with dCTP:dC). Ignoring dGTP:dT, the difference is 40-fold. The smallest difference in specificities, comparing mismatch to correct, is 2400-fold (dGTP:dT and dTTP:dA).


Figure 2
View larger version (44K):
[in this window]
[in a new window]

 
FIGURE 2.
Kinetic constants governing nucleotide selectivity. Each histogram compares kinetic parameters for each correct and incorrect base pair using data in Table 2. Base pairs are grouped according to the type of nucleotide pair according to the labels at the top of the figure. Note the ordinate is a log scale. A, variation in the maximum rate of polymerization, kpol(s-1). B, variation in the ground state dissociation constant, KdM). C, variation in the specificity constant, kpol/KdM-1 s-1). D, variation in the discrimination (kpol/Kd)correct/(kpol/Kd)incorrect. Note that by definition, the discrimination for the correct base pairs is unity.

 
Discrimination against misincorporation results from weaker ground state binding and slower rates catalyzed by T7 DNA polymerase, human immunodeficiency virus-1 reverse transcriptase, and rat polymerase beta (35-37). According to Kd and kpol values reported here and previously, exo- human Pol {gamma} also exhibits weaker ground state binding and decreased rates of polymerization for mismatched nucleotides. A C:C mispair was formed at the slowest rate, whereas the weak binding of dGTP provided selection against the formation of a G:A mispair. G:T mispairs have been observed to be relatively easily formed by other polymerases (37, 38), and human Pol {gamma} is no exception. Although T:T and G:T mispairings both have similarly tight dissociation constants (57 and 71 µM, respectively), Pol {gamma} catalyzes the incorporation of dGTP opposite a template dTMP 90-fold faster than it does a dTTP opposite a template dTMP. It is thought that aberrant base pair geometry slows the incorporation rate, whereas base pair hydrogen bonding contributes to selectivity in ground state binding (39). Although T:T and G:T mispairs both show similar and relatively tight ground state binding and presumably similar base pair hydrogen bonding, only the G:T mispair appears to maintain sufficiently normal base pair geometry to afford rapid incorporation subsequent to binding of the incoming nucleotide. Recently, a structural study of thermophilic Bacillus DNA polymerase I fragment, BF, complexed to terminally mispaired DNA strands showed that T:T mispairings do not alter the enzyme conformation; however, the incoming nucleotide is shifted into the major groove somewhat, thus breaking a hydrogen bond formed between the 3' hydroxyl and an active site residue, Asp-830, corresponding to Asp-1135 in Pol {gamma} and disrupting catalytic site assembly (40). The study also showed that although this enzyme adopts a distorted open conformation when bound to a G:T terminally mispaired DNA substrate, the G:T pair adopts a conformation similar to the cognate base pairing and that the 3' hydroxyl placement for catalysis remains nearly intact.

Perhaps more interesting than the comparison of T:T and G:T mispairs is the comparison of a G:T to a T:G mispairing. Our data suggest that base pair hydrogen bonding of the T:G mispair does not stabilize it to the same degree as for the G:T mispair (~3-fold higher Kd) and that the base pair geometry is more perturbed in the case of T:G than it is for G:T (~7-fold slower kpol). Data from the BF structural study (40) indicates that although the enzyme adopts a similar open conformation, a BF-DNA contact is disrupted in the T:G mispair structure and that an interaction between the primer 3' hydroxyl and an active site residue (Asp-830) is at least partially disrupted. No crystal structure is available for human Pol {gamma} as yet, but the kinetic parameters presented here suggest that binding of Pol {gamma} to terminally mispaired DNA substrates may be similar to that observed with BF.

Nucleotide discrimination can be calculated by dividing the specificity constant for correct nucleotide binding by the constant for incorrect binding (Fig. 2D). For example, the specificity constant for T:A incorporation is 41.7 s-1 µM-1, and the specificity constant for A:A misincorporation is 7.6 x 10-5 s-1 µM-1 resulting in a discrimination value of 550,000. We have previously calculated and reported an average fidelity of Pol {gamma} polymerization to be 1 error in 280,000 base pairs catalyzed. The studies presented in this paper allow us to calculate a more complete average fidelity of polymerization of 1 error in 440,000 bases incorporated. Pre-steady-state kinetic studies of exonuclease activity have defined the exonuclease proofreading contribution to fidelity of Pol {gamma} as a 4-200-fold increase (28). Combining the fidelity contributions from polymerization and exonuclease proofreading allows us to refine the previously reported overall fidelity of 1 error in 1.1-20 x 106 to a new overall fidelity of 1 error in 1.8 x 106-3.6 x 107 bases incorporated.

Fidelity of nucleotide incorporation by a DNA polymerase is a complex phenomenon created by a host of interactions including, but not limited to Watson-Crick interactions, base stacking, nearest neighbor interactions, and enzyme-substrate contacts within the active site of the polymerase. Experiments in aqueous solution have shown a trend in base stacking interactions, where deoxyguanosine stacks most strongly followed by deoxyadenosine, deoxycytosine, and deoxythymidine in order (41). Additionally, it has been shown that due to the exclusion of water in the active site of DNA polymerases, base stacking interactions are stronger than would otherwise be expected (41, 42). In the experiments that are presented in this paper, only a single DNA primer was employed to investigate the fidelity of nucleotide incorporation. Because only deoxyadenosine was tested as the base directly 5' of the position of incorporation, the results presented here may be biased. However, because only one primer sequence was employed, the data are more easily compared directly, as primer sequence is removed as a possible source of variability. It has been previously shown with T4 DNA polymerase that replication fidelity is highest when either deoxyguanosine or deoxyadenosine are present in the primer directly 5' of the site of incorporation (43). Although experiments to determine the effects of nearest neighbors on discrimination have not been carried out with Pol {gamma}, data from T4 DNA polymerase suggest that the overall discrimination that we have calculated for Pol {gamma} may be a high estimate. Further experimentation employing primers and templates differing in sequence from those used previously should allow for further refinement of the estimate of nucleotide discrimination by human mitochondrial DNA Pol {gamma} without ambiguity or bias.


    FOOTNOTES
 
* This work was supported by National Institutes of Health Grant R01 GM044613 and by The Welch Foundation Grant F-1604. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Institute for Cellular and Molecular Biology, University of Texas at Austin, 2500 Speedway, A4800, Austin, TX 78712. Tel.: 512-471-0434; Fax: 512-471-0435; E-mail: kajohnson{at}mail.utexas.edu.

2 The abbreviations used are: Pol {gamma}, human mitochondrial DNA polymerase holoenzyme; BF, Bacillus DNA polymerase I fragment; Pur, purine; Pyr, pyrimidine. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Pesole, G., Gissi, C., De Chirico, A., and Saccone, C. (1999) J. Mol. Evol. 48, 427-434[CrossRef][Medline] [Order article via Infotrieve]
  2. Taylor, R. W., Giordano, C., Davidson, M. M., d'Amati, G., Bain, H., Hayes, C. M., Leonard, H., Barron, M. J., Casali, C., Santorelli, F. M., Hirano, M., Lightowlers, R. N., DiMauro, S., and Turnbull, D. M. (2003) J. Am. Coll. Cardiol. 41, 1786-1796[Abstract/Free Full Text]
  3. Taylor, R. W., and Turnbull, D. M. (2005) Nat. Rev. Genet. 6, 389-402[Medline] [Order article via Infotrieve]
  4. Santorelli, F. M., Mak, S. C., El Schahawi, M., Casali, C., Shanske, S., Baram, T. Z., Madrid, R. E., and DiMauro, S. (1996) Am. J. Hum. Genet. 58, 933-939[Medline] [Order article via Infotrieve]
  5. Santorelli, F. M., Barmada, M. A., Pons, R., Zhang, L. L., and DiMauro, S. (1996) Neurology 47, 1320-1323[Abstract/Free Full Text]
  6. He, L., Luo, L., Proctor, S. J., Middleton, P. G., Blakely, E. L., and Taylor, R. W. (2003) Leukemia 17, 2487-2491[CrossRef][Medline] [Order article via Infotrieve]
  7. Graf, W. D., Marin-Garcia, J., Gao, H. G., Pizzo, S., Naviaux, R. K., Markusic, D., Barshop, B. A., Courchesne, E., and Haas, R. H. (2000) J. Child Neurol. 15, 357-361[Abstract/Free Full Text]
  8. Holt, I. J., Harding, A. E., and Morganhughes, J. A. (1988) Nature 331, 717-719[CrossRef][Medline] [Order article via Infotrieve]
  9. Carelli, V., Ross-Cisneros, F. N., and Sadun, A. A. (2004) Prog. Retin. Eye Res. 23, 53-89[CrossRef][Medline] [Order article via Infotrieve]
  10. Squires, K. E. (2001) Antiviral Ther. 6, Suppl. 3, 1-14[Medline] [Order article via Infotrieve]
  11. Lewis, W. (2003) Antiviral Res. 58, 189-197[Medline] [Order article via Infotrieve]
  12. Lewis, W., Copeland, W. C., and Day, B. J. (2001) Lab. Investig. 81, 777-790[Medline] [Order article via Infotrieve]
  13. Lewis, W., Haase, C. P., Raidel, S. M., Russ, R. B., Sutliff, R. L., Hoit, B. D., and Samarel, A. M. (2001) Lab. Investig. 81, 1527-1536[Medline] [Order article via Infotrieve]
  14. Johnson, A. A., Ray, A. S., Hanes, J., Suo, Z., Colacino, J. M., Anderson, K. S., and Johnson, K. A. (2001) J. Biol. Chem. 276, 40847-40857[Abstract/Free Full Text]
  15. Lee, H., Hanes, J., and Johnson, K. A. (2003) Biochemistry 42, 14711-14719[CrossRef][Medline] [Order article via Infotrieve]
  16. Wernette, C. M., Conway, M. C., and Kaguni, L. S. (1988) Biochemistry 27, 6046-6054[CrossRef][Medline] [Order article via Infotrieve]
  17. Kunkel, T. A., and Mosbaugh, D. W. (1989) Biochemistry 28, 988-995[CrossRef][Medline] [Order article via Infotrieve]
  18. Kunkel, T. A., and Soni, A. (1988) J. Biol. Chem. 263, 4450-4459[Abstract/Free Full Text]
  19. Kunkel, T. A. (1985) J. Biol. Chem. 260, 12866-12874[Abstract/Free Full Text]
  20. Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly, Y., Gidlof, S., Oldfors, A., Wibom, R., Tornell, J., Jacobs, H. T., and Larsson, N. G. (2004) Nature 429, 417-423[CrossRef][Medline] [Order article via Infotrieve]
  21. Longley, M. J., Nguyen, D., Kunkel, T. A., and Copeland, W. C. (2001) J. Biol. Chem. 276, 38555-38562[Abstract/Free Full Text]
  22. Minnick, D. T., Liu, L., Grindley, N. D., Kunkel, T. A., and Joyce, C. M. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 1194-1199[Abstract/Free Full Text]
  23. Johnson, A. A., and Johnson, K. A. (2001) J. Biol. Chem. 276, 38090-38096[Abstract/Free Full Text]
  24. Carrodeguas, J. A., Theis, K., Bogenhagen, D. F., and Kisker, C. (2001) Mol. Cell 7, 43-54[CrossRef][Medline] [Order article via Infotrieve]
  25. Johnson, A. A., Tsai, Y., Graves, S. W., and Johnson, K. A. (2000) Biochemistry 39, 1702-1708[CrossRef][Medline] [Order article via Infotrieve]
  26. Graves, S. W., Johnson, A. A., and Johnson, K. A. (1998) Biochemistry 37, 6050-6058[CrossRef][Medline] [Order article via Infotrieve]
  27. Hanes, J. W., Thal, D. M., and Johnson, K. A. (2006) J. Biol. Chem. 281, 36241-36248[Abstract/Free Full Text]
  28. Johnson, A. A., and Johnson, K. A. (2001) J. Biol. Chem. 276, 38097-38107[Abstract/Free Full Text]
  29. Kaguni, L. S., and Olson, M. W. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6469-6473[Abstract/Free Full Text]
  30. Patel, S. S., Wong, I., and Johnson, K. A. (1991) Biochemistry 30, 511-525[CrossRef][Medline] [Order article via Infotrieve]
  31. Tsai, Y. C., and Johnson, K. A. (2006) Biochemistry 45, 9675-9687[CrossRef][Medline] [Order article via Infotrieve]
  32. Boosalis, M. S., Petruska, J., and Goodman, M. F. (1987) J. Biol. Chem. 262, 14689-14696[Abstract/Free Full Text]
  33. Lim, S. E., and Copeland, W. C. (2001) J. Biol. Chem. 276, 23616-23623[Abstract/Free Full Text]
  34. Kim, T. W., Brieba, L. G., Ellenberger, T., and Kool, E. T. (2006) J. Biol. Chem. 281, 2289-2295[Abstract/Free Full Text]
  35. Wong, I., Patel, S. S., and Johnson, K. A. (1991) Biochemistry 30, 526-537[CrossRef][Medline] [Order article via Infotrieve]
  36. Werneburg, B. G., Ahn, J., Zhong, X. J., Hondal, R. J., Kraynov, V. S., and Tsai, M. D. (1996) Biochemistry 35, 7041-7050[CrossRef][Medline] [Order article via Infotrieve]
  37. Kati, W. M., Johnson, K. A., Jerva, L. F., and Anderson, K. S. (1992) J. Biol. Chem. 267, 25988-25997[Abstract/Free Full Text]
  38. Ahn, J., Werneburg, B. G., and Tsai, M. D. (1997) Biochemistry 36, 1100-1107[CrossRef][Medline] [Order article via Infotrieve]
  39. Johnson, K. A. (1993) Annu. Rev. Biochem. 62, 685-713[CrossRef][Medline] [Order article via Infotrieve]
  40. Johnson, S. J., and Beese, L. S. (2004) Cell 116, 803-816[CrossRef][Medline] [Order article via Infotrieve]
  41. Petruska, J., Sowers, L. C., and Goodman, M. F. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 1559-1562[Abstract/Free Full Text]
  42. Petruska, J., Goodman, M. F., Boosalis, M. S., Sowers, L. C., Cheong, C., and Tinoco, I. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 6252-6256[Abstract/Free Full Text]
  43. Pless, R. C., and Bessman, M. J. (1983) Biochemistry 22, 4905-4915[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Andrieux and P. Gaspard
From the Cover: Nonequilibrium generation of information in copolymerization processes
PNAS, July 15, 2008; 105(28): 9516 - 9521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Fowler, J. A. Brown, K. A. Johnson, and Z. Suo
Kinetic Investigation of the Inhibitory Effect of Gemcitabine on DNA Polymerization Catalyzed by Human Mitochondrial DNA Polymerase
J. Biol. Chem., May 30, 2008; 283(22): 15339 - 15348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R Lee, S. A. Helquist, E. T. Kool, and K. A. Johnson
Base Pair Hydrogen Bonds Are Essential for Proofreading Selectivity by the Human Mitochondrial DNA Polymerase
J. Biol. Chem., May 23, 2008; 283(21): 14411 - 14416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R. Lee, S. A. Helquist, E. T. Kool, and K. A. Johnson
Importance of Hydrogen Bonding for Efficiency and Specificity of the Human Mitochondrial DNA Polymerase
J. Biol. Chem., May 23, 2008; 283(21): 14402 - 14410.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. W. Hanes and K. A. Johnson
A novel mechanism of selectivity against AZT by the human mitochondrial DNA polymerase
Nucleic Acids Res., November 29, 2007; 35(20): 6973 - 6983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R. Lee and K. A. Johnson
Fidelity and Processivity of Reverse Transcription by the Human Mitochondrial DNA Polymerase
J. Biol. Chem., November 2, 2007; 282(44): 31982 - 31989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Hanes, D. M. Thal, and K. A. Johnson
Incorporation and Replication of 8-Oxo-deoxyguanosine by the Human Mitochondrial DNA Polymerase
J. Biol. Chem., November 24, 2006; 281(47): 36241 - 36248.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/47/36236    most recent
M607964200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H. R.
Right arrow Articles by Johnson, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H. R.
Right arrow Articles by Johnson, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement